| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/2011 | WO2011011384A9 Synthesis of dendrimer conjugates |
| 07/21/2011 | WO2011008956A3 Mammalian genes involved in infection |
| 07/21/2011 | WO2010141879A3 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 07/21/2011 | WO2010108164A8 Novel anti-parasitic compounds |
| 07/21/2011 | US20110179509 Use of Afamin for Treating Fertility Disorders |
| 07/21/2011 | US20110179506 New i-crei derived single-chain meganuclease and uses thereof |
| 07/21/2011 | US20110179505 Rodent cancer model for human fgfr4 arg388 polymorphism |
| 07/21/2011 | US20110179502 Modulation of gm98 (mrf) in remyelination |
| 07/21/2011 | US20110178488 Sexual Hygienic Composition |
| 07/21/2011 | US20110178270 T-cell death-inducing epitopes |
| 07/21/2011 | US20110178160 Inhibition of Interaction of PSD93 and PSDS95 with nNOS and NMDA Receptors |
| 07/21/2011 | US20110178102 Sir2 regulation |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 07/21/2011 | US20110178030 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 07/21/2011 | US20110178029 Modified Human Apolipoprotein A-1 and Their Uses |
| 07/21/2011 | US20110178028 Method for the detection of proventricular dilatation disease and kit thereof |
| 07/21/2011 | US20110178027 Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents |
| 07/21/2011 | US20110178026 Ricin-like toxins for treatment of cancer |
| 07/21/2011 | US20110178025 Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation |
| 07/21/2011 | US20110178024 Amyloid beta-peptides and methods of use thereof |
| 07/21/2011 | US20110178023 Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands |
| 07/21/2011 | US20110178022 Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction |
| 07/21/2011 | US20110178021 Opiorphin for use as a psychostimulant agent |
| 07/21/2011 | US20110178020 Methods and compositions for inhibition of neutrophil exocytosis |
| 07/21/2011 | US20110178019 New protecting compositions for recombinantly produced factor viii |
| 07/21/2011 | US20110178018 Novel selenium-containing compounds |
| 07/21/2011 | US20110178017 Modified vasoactive intestinal peptides |
| 07/21/2011 | US20110178016 Pulse parathyroid hormone for treatment of the hematopoietic syndrome, stromal cell loss, and vascular injury resulting from acute exposure to lethal radiation |
| 07/21/2011 | US20110178015 Methods of treatment using biased ligands for receptors such as the pth receptor |
| 07/21/2011 | US20110178014 Prevention and treatment of cardiac arrhythmias |
| 07/21/2011 | US20110178013 Novel octapeptide compounds derived from somatostatin and the therapeutic use thereof |
| 07/21/2011 | US20110178012 Use of human chorionic gonadotropin orally for the treatment of overweight (obesity) associated with high blood tension, non-insulin-dependant diabetes, hypercholesterolemia, dyslipidemias and lipodystrophy. |
| 07/21/2011 | US20110178011 Polysaccharide/BMP complexes which are soluble at physiological pH |
| 07/21/2011 | US20110178010 Use of peptides for promoting wound healing |
| 07/21/2011 | US20110178009 Pheromones and the Luteinizing Hormone for Inducing Proliferation of Neural Stem Cells and Neurogenesis |
| 07/21/2011 | US20110178008 Compositions for Enhancing the Production of PPAR and/or PPAR-Associated Factors |
| 07/21/2011 | US20110178007 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110178005 Compositions and methods for treating disorders associated with overweight animals |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110178003 Optimized dengue virus entry inhibitory peptide (10an) |
| 07/21/2011 | US20110178002 High Affinity Ligands Bind to Clostridium Difficile Toxin A |
| 07/21/2011 | US20110178001 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 07/21/2011 | US20110178000 Apoptotically Active Peptides |
| 07/21/2011 | US20110177999 Therapeutic Combinations Useful in Treating CFTR Related Diseases |
| 07/21/2011 | US20110177998 Bioactive peptides and methods of using same |
| 07/21/2011 | US20110177997 Cross-Beta Silk Genes |
| 07/21/2011 | US20110177996 Regulatory proteins in lung repair and treatment of lung disease |
| 07/21/2011 | US20110177972 Compositions and methods for the treatment of immune related diseases |
| 07/21/2011 | US20110177581 Mutant MT-SP1 proteases with altered substrate specificity or activity |
| 07/21/2011 | US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides |
| 07/21/2011 | US20110177554 Secreted frizzled related protein, sfrp, fragments and methods of use thereof |
| 07/21/2011 | US20110177528 Methods for detecting and inhibiting angiogenesis |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177167 Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177152 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease |
| 07/21/2011 | US20110177151 Implantable material and a method for the preparation thereof |
| 07/21/2011 | US20110177140 4-amidino benzylamines for cosmetic and/or dermatological use |
| 07/21/2011 | US20110177135 Methods of treating cartilage defects |
| 07/21/2011 | US20110177101 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 07/21/2011 | US20110177098 Tm4sf4 and modulators thereof and methods for their use |
| 07/21/2011 | US20110177097 Methods for modulating expression of creb |
| 07/21/2011 | US20110177093 Use of bcma as an immunoregulatory agent |
| 07/21/2011 | US20110177089 Apoptosis inducer |
| 07/21/2011 | US20110177088 Method for Treating and Diagnosing Hematologic Malignancies |
| 07/21/2011 | US20110177085 Bitter Taste Receptors |
| 07/21/2011 | US20110177084 Novel use application of sugar chain-recognizing receptor |
| 07/21/2011 | US20110177083 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 07/21/2011 | US20110177082 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/21/2011 | US20110177069 Novel inducer of chondrocyte proliferation and differentiation |
| 07/21/2011 | US20110177066 Prevention and treatment of amyloidogenic diseases |
| 07/21/2011 | US20110177065 Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
| 07/21/2011 | US20110177060 Iap bir domain binding compounds |
| 07/21/2011 | US20110177058 Methods and compositions for modulating hgf/met |
| 07/21/2011 | US20110177057 Pharmaceutical preparation and manufacturing method thereof |
| 07/21/2011 | US20110177056 Non-cytotoxic fusion proteins comprising egf muteins |
| 07/21/2011 | US20110177055 Compounds and compositions as channel activating protease inhibitors |
| 07/21/2011 | US20110177054 Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna |
| 07/21/2011 | US20110177053 Non-cytotoxic protein conjugates |
| 07/21/2011 | US20110177052 Stabilized Proteases For Use In Skin Care |
| 07/21/2011 | US20110177051 Methods and compositions for treatment of mitochondrial disorders |
| 07/21/2011 | US20110177050 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177049 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177048 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 07/21/2011 | US20110177047 Methods and compositions for preventing or treating ophthalmic conditions |
| 07/21/2011 | US20110177046 Dithiazolidine and thiazolidine derivatives as anticancer agents |
| 07/21/2011 | US20110177043 Method of improving differentiation of chondrogenic progenitor cells |
| 07/21/2011 | US20110177038 Inhibition of Tumor Growth via Peroxiredoxin 3 |
| 07/21/2011 | US20110177030 Hepatitis C Inhibitor Compounds |
| 07/21/2011 | US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases |
| 07/21/2011 | US20110177028 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 07/21/2011 | US20110177027 COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha |
| 07/21/2011 | US20110177026 Use of Alpha-Glucosidase Inhibitors to Treat Alphavirus Infections |
| 07/21/2011 | US20110177025 Wound healing |
| 07/21/2011 | US20110177024 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 07/21/2011 | US20110177023 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
| 07/21/2011 | US20110177022 Mammalian Cytokines; Related Reagents and Methods |
| 07/21/2011 | US20110177021 Composition for forming a temporary obstruction and method of forming the same |